|
 |
Company Introduction |
Wuhan Daan pharmaceutical co., Ltd. Wuhan Daan pharmaceutical co., Ltd. was founded in 2003, is a professional drug product research and development, production and sales of high-tech pharmaceutical enterprise, dedicated to targeted drug delivery products and industrialization of innovative dosage forms of drugs. built has to enjoy State special allowance of famous drug expert for technology leader of Medicine Institute, is national new policy developed Hou Hubei Province finds of first batch high-tech enterprise list in the Wuhan only a WINS of medicine manufacturing enterprise, and was as Hubei Province and Wuhan listed reserve enterprise, is Huazhong University of Tongji Medical College pharmacy teaching base, Hubei Province research major project, and Wuhan autonomous innovation project main implementation units. |
the company is located in gold and Silver Lake ecological park in Wuhan dongxihu district Taiwanese investment zone, covers an area of 80,000 square meters. a project investment of 60 million Yuan, has now completed the construction of large volume injection, Lyophilized Powder for Injection, small volume injection, three production lines and raw materials such as GMP workshop, and has targeted drug delivery products industrialization of technological capabilities. already has 16 rules of medicine has produced documents relating to and go on sale, including plasma substitute, parenteral nutritional medicine, antiviral, anti-infection drugs, listing applications of another 13 medicines has been reported that the SFDA for approval.   company now employs 200 people, including 1 professors, PhD 1, master 5 people, 6 people of practising pharmacists, college degree or above a staff of 70 people, 38.9% per cent of total number of employees, research and development staff of 35, 19.4% per cent of total number of employees.   company beginning, has spent more than 10 million Yuan to build its own core technologies and research and development platform--Center for drug research and development, in a very strong spirit of innovation has launched a domestic leading technology level of injections and raw. has the advanced production equipment, first-class pharmaceutical technology, experienced technical staff, and the establishment of efficient and strict quality management system, with high, new, sharp raw material medicine, transfusion products, lyophilized powder, lipid Microsphere agents in small capacity injection product and production capacity.   company development strategies into the nation's largest, most professional targeted drug manufacturers, completion of targeting drug delivery systems (TDDS) technology platform, on market prospects for secondary development of drugs, based on access to pharmaceutical products and core technologies of the market advantage.   since 2005 production, company GMP management specification, perfect marketing network, has achieved rapid growth in sales of existing varieties. the company's existing commercial 1500, in which provincial market coverage of 96%, municipal market coverage 65%, 58% County market coverage. product has entered the 5,420 all kinds of large and medium sized hospitals in the country, three level coverage 29%, 36% level II hospital coverage, coverage levels and other hospital 8%; participation per cent currently, 158, 29 districts nationwide bidding, cumulative tenders 896, participation rates up to 100%. bid-winning rate of 75%, in the province, municipalities of consolidated bidding areas, successful rate of up to 90%. better educated, younger Daan Pharmacy staff, give full play to science and technology and modern enterprise management advantages, effective implementation of GMP Standardization Management, accelerating technological progress, realizing enterprise sustainable development. This enterprise in order to "do everything for people's health" as its mission, establish a brand strategy, follow the road of sustainable development. insist on quality first, fully committed to the cause of human health, a vibrant, vigorous pharmaceutical companies will be displayed at the forest of modern pharmaceutical industries in China. | 。
|